Actively Recruiting

Age: 18Years +
All Genders
ID05001087

A Physician & Patient-powered Cohort Registry for Multiple Myeloma in Italy

Led by Fondazione EMN Italy Onlus · Updated on 2025-02-27

1900

Participants Needed

27

Research Sites

N/A

Total Duration

On this page

Sponsors

F

Fondazione EMN Italy Onlus

Lead Sponsor

A

Amgen

Collaborating Sponsor

AI-Summary

What this Trial Is About

This observational study aims to create a national registry in Italy for multiple myeloma to monitor routine clinical practice and describe the standard care used for diagnosis and treatment. Multiple myeloma accounts for a small percentage of tumor diagnoses in Italy, with incidence rates of 9.5 per 100,000 males and 8.1 per 100,000 females. The registry will help analyze current treatment patterns and patient demographics to address future changes in care. The study involves a non-interventional, multicenter registry collecting both retrospective and prospective data from patients diagnosed with multiple myeloma since January 1, 2019. Data will be gathered using an electronic platform, and patients will be enrolled consecutively during their regular appointments after providing informed consent. Patients participating in other studies can also be included, with baseline and survival data collected for those in interventional trials. Participants will have hospital visits every six months, where clinical data and patient-reported outcomes will be recorded. Researchers will assess overall survival and time to next treatment over three years, along with patient-reported outcomes and costs incurred by patients. The study provides long-term monitoring without altering patients' usual care, and participation duration may vary depending on individual follow-up.

CONDITIONS

Brief Title

A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients of both sexes
  • Age 18 years or older
  • Diagnosis of active or symptomatic multiple myeloma made no earlier than January 1, 2019
  • Able and willing to sign an informed consent form
Not Eligible

You will not qualify if you...

  • None considered

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 3 years

Participants who undergo routine care are observed with data collected to monitor multiple myeloma progression and outcomes.

Visits approximately every 6 months

Trial Site Locations

Total: 27 locations

1

A.O.U di Careggi

Florence, Firenze, Italy, 50134

Actively Recruiting

2

AOU Ospedali Riuniti Umberto I

Ancona, Italy

Actively Recruiting

3

Policlinico di Bari - Ematologia con Trapianto

Bari, Italy

Not Yet Recruiting

4

Policlinico di Bari

Bari, Italy

Actively Recruiting

5

Policlinico S. Orsola

Bologna, Italy

Actively Recruiting

6

A.O. Spedali Civili di Brescia

Brescia, Italy

Actively Recruiting

7

AOU Policlinico Vittorio Emanuele

Catania, Italy

Actively Recruiting

8

A.O.U Policlinico S. Martino

Genova, Italy

Actively Recruiting

9

ASST Santi Paolo e Carlo

Milan, Italy

Actively Recruiting

10

Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico

Milan, Italy

Actively Recruiting

11

Istituto Nazionale Tumori

Milan, Italy

Actively Recruiting

12

Ospedale Niguarda Cà Grande

Milan, Italy

Actively Recruiting

13

Ospedale San Gerardo di Monza

Monza, Italy

Actively Recruiting

14

A.O.U Federico II

Naples, Italy

Not Yet Recruiting

15

Ospedale Maggiore

Novara, Italy

Actively Recruiting

16

A.O.U di Parma

Parma, Italy

Actively Recruiting

17

Policlinico San Matteo Fondazione IRCCS

Pavia, Italy

Actively Recruiting

18

Ospedale "Infermi"

Rimini, Italy

Terminated

19

Ospedale S. Eugenio

Roma, Italy

Actively Recruiting

20

Policlinico Umberto I - Università La Sapienza

Roma, Italy

Actively Recruiting

21

Policlinico Universitario Campus Biomedico

Roma, Italy

Actively Recruiting

22

IRCCS Ospedale Casa Sollievo della Sofferenza

San Giovanni Rotondo, Italy

Actively Recruiting

23

A.O. Santa Maria

Terni, Italy

Actively Recruiting

24

A.O Ordine Mauriziano

Torino, Italy

Actively Recruiting

25

AOU Città della Salute e della Scienza di Torino

Torino, Italy

Actively Recruiting

26

Policlinico Universitario di Udine

Udine, Italy

Actively Recruiting

27

Ospedale di Circolo

Varese, Italy

Actively Recruiting

Loading map...

Research Team

M

Mario Boccadoro

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multi...

Multiple Myeloma

Actively Recruiting

1 location

Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematolog...

Multiple Myeloma

Actively Recruiting

1 location

Study Evaluating Safety and Efficacy of BCMA-Targeted Prime ...

Multiple Myeloma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here